1 study found for:    12531805 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: sunitinib and rapamycin (Drug will be held)

Indicates status has not been verified in more than two years